BriaCell Therapeutics Corp. (BCTX) vs DocGo Inc. (DCGO)
A side-by-side comparison of BriaCell Therapeutics Corp. and DocGo Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BCTX
BriaCell Therapeutics Corp.
$4.05HealthcareDelayed quote: Oct 6, 2026, 2:59 PM EDT
DCGO
DocGo Inc.
$0.36HealthcareDelayed quote: Oct 6, 2026, 2:59 PM EDT
Total return — BCTX vs DCGO
growth of $100 · dividends reinvested · last 6yBCTX -99.3% (-56.0%/yr)DCGO -96.5% (-42.7%/yr)DCGO compounded faster over this window
BCTX DCGO
BCTX vs DCGO: by the numbers
- •DCGO is the larger company ($35M vs $35M market cap).
- •Both run net losses; BCTX's is the smaller (0.00% vs -65.29% net margin).
Metrics side by side
Valuation
| Metric | BCTX | DCGO |
|---|---|---|
| P/S ratio | N/A | 0.12 |
| P/B ratio | 1.46 | 0.30 |
Profitability
| Metric | BCTX | DCGO |
|---|---|---|
| Gross margin | 0.00% | 30.12% |
| Operating margin | 0.00% | -27.67% |
| Net margin | 0.00% | -65.29% |
| ROE | -154.06% | -161.63% |
| ROIC | -164.58% | -89.44% |
Growth (annualized)
| Metric | BCTX | DCGO |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 11.63% |
| Total return CAGR (5Y) | -67.32% | -48.40% |
Frequently asked
- How have BCTX and DCGO total returns compared?
- Over the past 5 years, BCTX delivered -67.32% and DCGO delivered -48.40% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.